Novartis Investigative Site

Pommelsbrunn 91224

0 studies enrolling now · 3 studies all time

What they study most

Acne Vulgaris, Chronic Plaque Type Psoriasis, Moderate to Severe Plaque-type Psoriasis

Studies at this site

• Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne — Completed
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens — Completed